Cargando…
Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil
Objectives: The aim of this study is to evaluate some mechanisms of the immune response of people infected with SARS-CoV-2 in both acute infection and early and late convalescence phases. Methods: This is a cohort study of 70 cases of COVID-19, confirmed by RT-PCR, followed up to 60 days. Plasma Sam...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385121/ https://www.ncbi.nlm.nih.gov/pubmed/37515295 http://dx.doi.org/10.3390/v15071609 |
_version_ | 1785081325403766784 |
---|---|
author | Pacheco, Vanessa Cuber Guimarães, Rosane Corrêa-Moreira, Danielly Magalhães, Carlos Eduardo Figueiredo, Douglas Guttmann, Patricia Trindade, Gisela Freitas da Silva, Juliana Fernandes Amorim Ano Bom, Ana Paula Dinis de Lourdes Maia, Maria Melgaço, Juliana Gil da Costa Barros, Tamiris Azamor da Silva, Andrea Marques Vieira Oliveira, Manoel Marques Evangelista |
author_facet | Pacheco, Vanessa Cuber Guimarães, Rosane Corrêa-Moreira, Danielly Magalhães, Carlos Eduardo Figueiredo, Douglas Guttmann, Patricia Trindade, Gisela Freitas da Silva, Juliana Fernandes Amorim Ano Bom, Ana Paula Dinis de Lourdes Maia, Maria Melgaço, Juliana Gil da Costa Barros, Tamiris Azamor da Silva, Andrea Marques Vieira Oliveira, Manoel Marques Evangelista |
author_sort | Pacheco, Vanessa |
collection | PubMed |
description | Objectives: The aim of this study is to evaluate some mechanisms of the immune response of people infected with SARS-CoV-2 in both acute infection and early and late convalescence phases. Methods: This is a cohort study of 70 cases of COVID-19, confirmed by RT-PCR, followed up to 60 days. Plasma Samples and clinical data were. Viral load, blood count, indicators inflammation were the parameters evaluated. Cellular immune response was evaluated by flow cytometry and Luminex immunoassays. Results: In the severe group, hypertension was the only reported comorbidity. Non severe patients have activated memory naive CD4+ T cells. Critically ill patients have central memory CD4+ T cell activation. Severe COVID-19 patients have both central memory and activated effector CD8+ T cells. Non-severe COVID-19 cases showed an increase in IL1β, IL-6, IL-10 and TNF and severely ill patients had higher levels of the cytokines IL-6, IL-10 and CXCL8. Conclusions: The present work showed that different cellular responses are observed according to the COVID-19 severity in patients from Brazil an epicenter the pandemic in South America. Also, we notice that some cytokines can be used as predictive markers for the disease outcome, possibility implementation of strategies effective by health managers. |
format | Online Article Text |
id | pubmed-10385121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103851212023-07-30 Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil Pacheco, Vanessa Cuber Guimarães, Rosane Corrêa-Moreira, Danielly Magalhães, Carlos Eduardo Figueiredo, Douglas Guttmann, Patricia Trindade, Gisela Freitas da Silva, Juliana Fernandes Amorim Ano Bom, Ana Paula Dinis de Lourdes Maia, Maria Melgaço, Juliana Gil da Costa Barros, Tamiris Azamor da Silva, Andrea Marques Vieira Oliveira, Manoel Marques Evangelista Viruses Article Objectives: The aim of this study is to evaluate some mechanisms of the immune response of people infected with SARS-CoV-2 in both acute infection and early and late convalescence phases. Methods: This is a cohort study of 70 cases of COVID-19, confirmed by RT-PCR, followed up to 60 days. Plasma Samples and clinical data were. Viral load, blood count, indicators inflammation were the parameters evaluated. Cellular immune response was evaluated by flow cytometry and Luminex immunoassays. Results: In the severe group, hypertension was the only reported comorbidity. Non severe patients have activated memory naive CD4+ T cells. Critically ill patients have central memory CD4+ T cell activation. Severe COVID-19 patients have both central memory and activated effector CD8+ T cells. Non-severe COVID-19 cases showed an increase in IL1β, IL-6, IL-10 and TNF and severely ill patients had higher levels of the cytokines IL-6, IL-10 and CXCL8. Conclusions: The present work showed that different cellular responses are observed according to the COVID-19 severity in patients from Brazil an epicenter the pandemic in South America. Also, we notice that some cytokines can be used as predictive markers for the disease outcome, possibility implementation of strategies effective by health managers. MDPI 2023-07-23 /pmc/articles/PMC10385121/ /pubmed/37515295 http://dx.doi.org/10.3390/v15071609 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pacheco, Vanessa Cuber Guimarães, Rosane Corrêa-Moreira, Danielly Magalhães, Carlos Eduardo Figueiredo, Douglas Guttmann, Patricia Trindade, Gisela Freitas da Silva, Juliana Fernandes Amorim Ano Bom, Ana Paula Dinis de Lourdes Maia, Maria Melgaço, Juliana Gil da Costa Barros, Tamiris Azamor da Silva, Andrea Marques Vieira Oliveira, Manoel Marques Evangelista Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil |
title | Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil |
title_full | Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil |
title_fullStr | Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil |
title_full_unstemmed | Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil |
title_short | Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil |
title_sort | clinical profile of sars-cov-2 infection: mechanisms of the cellular immune response and immunogenetic markers in patients from brazil |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385121/ https://www.ncbi.nlm.nih.gov/pubmed/37515295 http://dx.doi.org/10.3390/v15071609 |
work_keys_str_mv | AT pachecovanessa clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT cuberguimaraesrosane clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT correamoreiradanielly clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT magalhaescarloseduardo clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT figueiredodouglas clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT guttmannpatricia clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT trindadegiselafreitas clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT dasilvajulianafernandesamorim clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT anobomanapauladinis clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT delourdesmaiamaria clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT melgacojulianagil clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT dacostabarrostamirisazamor clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT dasilvaandreamarquesvieira clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil AT oliveiramanoelmarquesevangelista clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil |